The focus of this presentation is on the pharmacology, indications, efficacy, side effects, and interactions of newer medications used in the field of urology. New concerns reported over the past year regarding cognitive dysfunction associated with anti-muscarinic agents are also addressed. Information presented is then used to help make clinical decisions in case-based patient care scenarios.
Contact hours available until 11/7/18.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation
Speaker Disclosures:
There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Learning Outcome:
At the conclusion of this activity, the learner will be able to describe medications now being used in the care of urology patients that are either new, or have new uses in the care of patients with urologic dysfunction or disease.